---
title: "NYSE American files to remove Calidi Biotherapeutics warrants from listing"
url: "https://aibio.space/news/nyse-american-files-remove-calidi-biotherapeutics-warrants-listing/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2024-10-28"
section: "Listings"
tickers: "AMEX:CLDI"
source: "https://www.sec.gov/Archives/edgar/data/1855485/000114331324000107/xslF25X02/primary_doc.xml"
summary: "The notice, dated October 28, 2024, covers the company's redeemable warrants with a $115.00 exercise price, not its common stock."
---

By the aibio.space news desk.

Sources

- [Calidi Biotherapeutics, Inc. 25-NSE (2024-10-28)](https://www.sec.gov/Archives/edgar/data/1855485/000114331324000107/xslF25X02/primary_doc.xml)

[CLDI](https://aibio.space/companies/calidi-biotherapeutics/)

2024-10-28

# NYSE American files to remove Calidi Biotherapeutics warrants from listing

Tickers [CLDI](https://aibio.space/companies/calidi-biotherapeutics/)

The notice, dated October 28, 2024, covers the company's redeemable warrants with a $115.00 exercise price, not its common stock.

## Key facts

- **Company**: Calidi Biotherapeutics, Inc. (AMEX: CLDI)

- **News type**: Listings

- **Primary source**: [Calidi Biotherapeutics, Inc. 25-NSE (2024-10-28)](https://www.sec.gov/Archives/edgar/data/1855485/000114331324000107/xslF25X02/primary_doc.xml)

*Marble steps and columns of a supreme court building. CC0, via rawpixel. The picture shows the field, not the companies named.*

NYSE American LLC has filed a notice with the Securities and Exchange Commission to remove the redeemable warrants of Calidi Biotherapeutics, Inc. from listing and registration. The notice is dated October 28, 2024.

The notice covers only the warrants. A warrant gives its holder the right to buy shares at a set price. According to the filing, each whole Calidi warrant is exercisable for one tenth of a share of common stock at an exercise price of $115.00.

The exchange filed the notice under 17 CFR 240.12d2-2(b), the SEC rule that covers removals started by an exchange rather than by the company. The common stock is not named in the notice. The form lists the company's address at 11110 Sunset Hills Road in Reston, Virginia, and its commission file number as 001-40789.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

CLDI

Calidi Biotherapeutics, Inc.

AMEX · United States

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/nyse-american-files-remove-calidi-biotherapeutics-warrants-listing/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "NYSE American files to remove Calidi Biotherapeutics warrants from listing", 2024-10-28, https://aibio.space/news/nyse-american-files-remove-calidi-biotherapeutics-warrants-listing/